STOCK TITAN

Cabot SEC Filings

CBT NYSE

Welcome to our dedicated page for Cabot SEC filings (Ticker: CBT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Locating the carbon black margin tables or environmental reserve footnotes in Cabot Corporation’s 250-page annual report can feel like hunting for a pigment in a dark vat. Our SEC Filings hub fixes that problem in seconds.

Stock Titan’s AI deciphers complexity: every Cabot Corporation annual report 10-K is auto-summarized, giving you a plain-English view of feedstock cost sensitivity, regional capacity additions, and sustainability liabilities. Need the latest Cabot Corporation quarterly earnings report 10-Q filing? It lands here the moment EDGAR releases it, paired with trend charts and ratio analysis.

Stop refreshing for insider trades—this page streams Cabot Corporation Form 4 insider transactions real-time. Track executive stock transactions before pricing cycles shift, and review historical Cabot Corporation insider trading Form 4 transactions for pattern analysis.

Unsure which filing answers your question? Type it naturally—“understanding Cabot Corporation SEC documents with AI” or “Cabot Corporation 8-K material events explained”—and our engine points you to the exact section. You’ll also find:

  • Cabot Corporation proxy statement executive compensation details with clear charts
  • Cabot Corporation earnings report filing analysis highlighting segment EBIT swings
  • Cabot Corporation annual report 10-K simplified into key risks and opportunities

Whether you’re a tire-sector analyst comparing reinforcement material margins or an ESG specialist reviewing remediation liabilities, our comprehensive coverage—with AI-powered summaries, real-time alerts, and clean navigation—lets you focus on decisions, not document mining.

Rhea-AI Summary

Sean D. Keohane, President and CEO and a director of Cabot Corporation (CBT), reported option exercises and open-market sales on 08/14/2025. He exercised two employee stock options totaling 114,436 shares (26,455 at $49.26 and 87,981 at $50.46) and sold 114,436 shares in multiple transactions at weighted average prices disclosed for each tranche, with sale prices in the reported ranges of $78.570 to $79.740. After these transactions he beneficially owned 361,518 shares directly and an additional 13,842.5928 shares indirectly through the company 401(k) plan trustee, for a combined disclosed position.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Filing
Rhea-AI Summary

Cabot Corporation (CBT) notice reports a proposed sale of 114,436 common shares, with an aggregate market value of $9,072,097.22, to be sold on 08/14/2025 through Fidelity Brokerage Services (NYSE). The filing shows the shares were acquired by exercise of options originally granted on 03/21/2016 (26,455 shares) and 11/11/2016 (87,981 shares) and that payment will be in cash. The filer states no securities of the issuer were sold by the same person in the past three months and attests they are not aware of undisclosed material adverse information about the issuer.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
quarterly report
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.38%
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

What is the current stock price of Cabot (CBT)?

The current stock price of Cabot (CBT) is $82.94 as of August 22, 2025.

What is the market cap of Cabot (CBT)?

The market cap of Cabot (CBT) is approximately 4.2B.
Cabot

NYSE:CBT

CBT Rankings

CBT Stock Data

4.22B
52.40M
1.22%
98.1%
4.08%
Specialty Chemicals
Miscellaneous Chemical Products
Link
United States
BOSTON